ArticleInflammatory bowel diseases2021

Corrigendum to: Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.